US 11364215
GHB formulation and method for its manufacture
granted A61KA61K31/19A61K31/785
Quick answer
US patent 11364215 (GHB formulation and method for its manufacture) held by Jazz Pharmaceuticals Ireland Limited expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Jazz Pharmaceuticals Ireland Limited
- Grant date
- Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/19, A61K31/785, A61K38/02, A61K9/10